| Characterising long COVID: a living systematic review M Michelen, L Manoharan, N Elkheir, V Cheng, A Dagens, C Hastie, ... BMJ Global Health 6 (9), e005427, 2021 | 802 | 2021 |
| Physical, cognitive, and mental health impacts of COVID-19 after hospitalisation (PHOSP-COVID): a UK multicentre, prospective cohort study RA Evans, H McAuley, EM Harrison, A Shikotra, A Singapuri, M Sereno, ... The Lancet Respiratory Medicine 9 (11), 1275-1287, 2021 | 499 | 2021 |
| Risk factors for post-COVID-19 condition in previously hospitalised children using the ISARIC Global follow-up protocol: a prospective cohort study IM Osmanov, E Spiridonova, P Bobkova, A Gamirova, A Shikhaleva, ... European Respiratory Journal 59 (2), 2022 | 323 | 2022 |
| Clinical characteristics with inflammation profiling of long COVID and association with 1-year recovery following hospitalisation in the UK: a prospective observational study RA Evans, OC Leavy, M Richardson, O Elneima, HJC McCauley, ... The Lancet Respiratory Medicine, 2022 | 309 | 2022 |
| Long Covid in adults discharged from UK hospitals after Covid-19: A prospective, multicentre cohort study using the ISARIC WHO Clinical Characterisation Protocol L Sigfrid, TM Drake, E Pauley, EC Jesudason, P Olliaro, WS Lim, ... The Lancet Regional Health-Europe 8, 100186, 2021 | 297 | 2021 |
| Co-infections, secondary infections, and antimicrobial use in patients hospitalised with COVID-19 during the first pandemic wave from the ISARIC WHO CCP-UK study: a multicentre … CD Russell, CJ Fairfield, TM Drake, L Turtle, RA Seaton, DG Wootton, ... The Lancet Microbe 2 (8), e354-e365, 2021 | 297 | 2021 |
| Development and validation of the ISARIC 4C Deterioration model for adults hospitalised with COVID-19: a prospective cohort study RK Gupta, EM Harrison, A Ho, AB Docherty, SR Knight, M van Smeden, ... The Lancet Respiratory Medicine 9 (4), 349-359, 2021 | 220 | 2021 |
| Mycobacterium ulcerans disease (Buruli ulcer) in rural hospital, Southern Benin, 1997–2001 M Debacker, J Aguiar, C Steunou, C Zinsou, WM Meyers, A Guédénon, ... Emerging infectious diseases 10 (8), 1391-1398, 2004 | 205 | 2004 |
| Incidence and risk factors for persistent symptoms in adults previously hospitalized for COVID‐19 D Munblit, P Bobkova, E Spiridonova, A Shikhaleva, A Gamirova, ... Clinical & Experimental Allergy 51 (9), 1107-1120, 2021 | 185 | 2021 |
| Outcomes among confirmed cases and a matched comparison group in the Long-COVID in Scotland study CE Hastie, DJ Lowe, A McAuley, AJ Winter, NL Mills, C Black, JT Scott, ... Nature communications 13 (1), 1-9, 2022 | 152 | 2022 |
| Characterisation of in-hospital complications associated with COVID-19 using the ISARIC WHO Clinical Characterisation Protocol UK: a prospective, multicentre cohort study TM Drake, AM Riad, CJ Fairfield, C Egan, SR Knight, R Pius, ... The Lancet 398 (10296), 223-237, 2021 | 148 | 2021 |
| Mycobacterium ulcerans disease: role of age and gender in incidence and morbidity M Debacker, J Aguiar, C Steunou, C Zinsou, WM Meyers, JT Scott, ... Tropical Medicine & International Health 9 (12), 1297-1304, 2004 | 140 | 2004 |
| A core outcome set for post-COVID-19 condition in adults for use in clinical practice and research: an international Delphi consensus study D Munblit, T Nicholson, A Akrami, C Apfelbacher, J Chen, W De Groote, ... The Lancet Respiratory Medicine, 2022 | 138 | 2022 |
| Asymptomatic infection and unrecognised Ebola virus disease in Ebola-affected households in Sierra Leone: a cross-sectional study using a new non-invasive assay for antibodies … JR Glynn, H Bower, S Johnson, CF Houlihan, C Montesano, JT Scott, ... The Lancet infectious diseases 17 (6), 645-653, 2017 | 122 | 2017 |
| Post-Ebola syndrome, Sierra Leone JT Scott, FR Sesay, TA Massaquoi, BR Idriss, F Sahr, MG Semple Emerging infectious diseases 22 (4), 641, 2016 | 120 | 2016 |
| Studying the post-COVID-19 condition: research challenges, strategies, and importance of Core Outcome Set development D Munblit, TR Nicholson, DM Needham, N Seylanova, C Parr, J Chen, ... BMC medicine 20 (1), 1-13, 2022 | 112 | 2022 |
| Experimental treatment of Ebola virus disease with brincidofovir J Dunning, SB Kennedy, A Antierens, J Whitehead, I Ciglenecki, ... PloS one 11 (9), e0162199, 2016 | 104 | 2016 |
| Changes in in-hospital mortality in the first wave of COVID-19: a multicentre prospective observational cohort study using the WHO Clinical Characterisation Protocol UK AB Docherty, RH Mulholland, NI Lone, CP Cheyne, D De Angelis, ... The Lancet Respiratory Medicine 9 (7), 773-785, 2021 | 98 | 2021 |
| Prevalence and risk factors of post-COVID-19 condition in adults and children at 6 and 12 months after hospital discharge: a prospective, cohort study in Moscow (StopCOVID) E Pazukhina, M Andreeva, E Spiridonova, P Bobkova, A Shikhaleva, ... BMC medicine 20 (1), 1-12, 2022 | 94 | 2022 |
| Non-steroidal anti-inflammatory drug use and outcomes of COVID-19 in the ISARIC Clinical Characterisation Protocol UK cohort: a matched, prospective cohort study TM Drake, CJ Fairfield, R Pius, SR Knight, L Norman, M Girvan, ... The Lancet Rheumatology 3 (7), e498-e506, 2021 | 88 | 2021 |
